
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.590 | 80.840 | 79.250 |
Shares | 98.410 | 98.410 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 7.589 | 16.924 |
Price to Book | 1.044 | 2.774 |
Price to Sales | 0.461 | 2.172 |
Price to Cash Flow | 3.824 | 10.634 |
Dividend Yield | 5.547 | 2.765 |
5 Years Earnings Growth | 12.905 | 11.997 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 28.110 | 20.303 |
Communication Services | 23.510 | 9.280 |
Healthcare | 16.930 | 12.025 |
Consumer Defensive | 13.320 | 7.912 |
Industrials | 10.160 | 14.181 |
Consumer Cyclical | 4.290 | 12.082 |
Real Estate | 3.670 | 4.472 |
Number of long holdings: 110
Number of short holdings: 61
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
GSK plc | GB00BN7SWP63 | 4.80 | 1,452.50 | -0.48% | |
Swiss Re | CH0126881561 | 4.65 | 144.90 | +0.03% | |
ING Groep | NL0011821202 | 4.61 | 20.36 | -1.07% | |
Standard Chartered | GB0004082847 | 4.47 | 1,386.00 | +0.80% | |
Orange | FR0000133308 | 4.41 | 13.90 | +1.24% | |
Carrefour | FR0000120172 | 4.36 | 12.365 | -0.36% | |
Etablissementen Franz Colruyt | BE0974256852 | 4.31 | 37.58 | -0.27% | |
AXA | FR0000120628 | 4.24 | 39.79 | -0.28% | |
Henkel ST | DE0006048408 | 4.13 | 65.65 | -0.68% | |
Sanofi | FR0000120578 | 3.88 | 84.49 | -1.02% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU0106261372 | 8.25B | 10.36 | 20.29 | 12.59 | ||
LU2032053097 | 4.47B | 9.42 | 2.84 | - | ||
LU0557290698 | 4.47B | 7.56 | 12.13 | 10.77 | ||
LU0225283513 | 4.3B | 11.62 | 17.28 | 9.37 | ||
LU1713307426 | 2.83B | 0.10 | -5.38 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review